Viral Vector Services

AAViator™

A comprehensive platform for AAV gene therapy development and manufacturing.


AAViator™ is a robust and reliable platform solution for AAV manufacturing. From in-house plasmid design and process development to GMP manufacturing, aseptic fill and finish, and analytical testing, our platform ensures high-quality, scalable production tailored to your needs.

With cutting-edge technology and deep expertise, AAViator™ streamlines the journey from preclinical research to commercial-scale production, supporting the advancement of transformative gene therapies.

  • From Design of Experiment (DoE) process development to clinical and commercial GMP manufacturing
  • Efficient and controlled upscaling of AAV vector production
  • No royalties applied
  • Full freedom to operate

Choose our premium plasmid DNA CDMO services for preclinical, clinical and commercial production. We adhere to the same GMP standards for producing Plasmid DNA, from the starting material to the final drug products.

In-house Plasmids

  • Freedom to operate, off-the-shelf plasmids
  • High quality, high yield
  • Backbones suitable for clinical trials
  • pHelper 100% free of fiber and hexon genes

Outstanding cell line

  • In-house HEK293 suspension cell line
  • Single cell growth, easy to transfect
  • High cell density, short doubling time
  • High-titer. high full/empty ratio

Upstream process

  • Robust and scalable upstream process

Downstream process

  • Design of Experiments (DoE) for novel capsids
  • Efficient enrichment of full capsids
  • Comprehensive purification solutions: TFF, Affinity and IEX Chromatography
  • Ultracentrifugation, if requested

Select our integrated Fill & Finish service chain for Drug Products including formulation, aseptic Fill & Finish, terminal sterilization or aseptic processing, visual inspection, in-house sterility testing, labeling, packaging, and Qualified Person certified release.

Aseptic Fill and Finish

  • Formulation and final drug product manufacturing including CCI testing
  • Packaging and labelling
  • QP release of IMP

Quality Control & Quality Assurance

  • Comprehensive in-house capabilities with 40+ assays
  • In-Process Control (IPC) and release testing
  • Full/empty measurements
  • Stability studies including analysis for vector stability

With you all the way…

together, making advanced biologics, and tomorrow’s life-transforming therapies.

We deliver unparalleled end-to-end development and manufacturing services for all protein expression systems and viral vectors, both for Drug Substances and Drug Products, from pre-clinical to clinical development and commercial phases.

We support our customers wherever they are on their journey, from early-stage development to commercialization. We are passionate, precise, and always close, together, making advanced biologics and tomorrow’s life-transforming therapies.


Pre-Clinical

Phase I

Phase II

Phase III

Commercial